Manage Patients Admitted on Rimegepant for Migraine Prophylaxis
August 2021
You may see rimegepant (Nurtec ODT) on med lists for migraine PREVENTION in adults.
It blocks receptors of calcitonin gene-related peptide (CGRP), a vasodilator and pain sensitizer that spikes during migraine attacks.
Until recently, rimegepant was only approved for acute treatment. And only the INJECTABLE CGRP antagonists, such as erenumab (Aimovig), were approved for prevention.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote